1. Home
  2. SYBX vs HCTI Comparison

SYBX vs HCTI Comparison

Compare SYBX & HCTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • HCTI
  • Stock Information
  • Founded
  • SYBX N/A
  • HCTI 2020
  • Country
  • SYBX United States
  • HCTI United States
  • Employees
  • SYBX N/A
  • HCTI N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • HCTI Retail: Computer Software & Peripheral Equipment
  • Sector
  • SYBX Health Care
  • HCTI Technology
  • Exchange
  • SYBX Nasdaq
  • HCTI Nasdaq
  • Market Cap
  • SYBX 16.4M
  • HCTI 13.5M
  • IPO Year
  • SYBX N/A
  • HCTI 2021
  • Fundamental
  • Price
  • SYBX $1.59
  • HCTI $2.58
  • Analyst Decision
  • SYBX
  • HCTI
  • Analyst Count
  • SYBX 0
  • HCTI 0
  • Target Price
  • SYBX N/A
  • HCTI N/A
  • AVG Volume (30 Days)
  • SYBX 19.9K
  • HCTI 749.5K
  • Earning Date
  • SYBX 11-11-2025
  • HCTI 11-13-2025
  • Dividend Yield
  • SYBX N/A
  • HCTI N/A
  • EPS Growth
  • SYBX N/A
  • HCTI N/A
  • EPS
  • SYBX N/A
  • HCTI N/A
  • Revenue
  • SYBX N/A
  • HCTI $11,866,000.00
  • Revenue This Year
  • SYBX N/A
  • HCTI N/A
  • Revenue Next Year
  • SYBX N/A
  • HCTI N/A
  • P/E Ratio
  • SYBX N/A
  • HCTI N/A
  • Revenue Growth
  • SYBX N/A
  • HCTI N/A
  • 52 Week Low
  • SYBX $0.90
  • HCTI $1.37
  • 52 Week High
  • SYBX $1.96
  • HCTI $473.10
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 64.64
  • HCTI 42.75
  • Support Level
  • SYBX $1.45
  • HCTI $2.24
  • Resistance Level
  • SYBX $1.54
  • HCTI $2.69
  • Average True Range (ATR)
  • SYBX 0.06
  • HCTI 0.21
  • MACD
  • SYBX 0.01
  • HCTI 0.20
  • Stochastic Oscillator
  • SYBX 94.74
  • HCTI 53.70

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About HCTI Healthcare Triangle Inc.

Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.

Share on Social Networks: